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Abstract: Exercise modulates metabolism and the gut microbiome. Brief exposure to low mT‐range
pulsing electromagnetic fields (PEMFs) was previously shown to accentuate in vitro myogenesis and
mitochondriogenesis by activating a calcium‐mitochondrial axis upstream of PGC‐1฀ transcriptional up-
regulation, recapitulating a genetic response implicated in exercise‐induced metabolic adaptations. We
compared the effects of analogous PEMF exposure (1.5 mT, 10 min/week), with and without exercise,
on systemic metabolism and gut microbiome in four groups of mice: (a) no intervention; (b) PEMF
treatment; (c) exercise; (d) exercise and PEMF treatment. The combination of PEMFs and exercise for
6 weeks enhanced running performance and upregulated muscular and adipose Pgc‐1฀ transcript levels,
whereas exercise alone was incapable of elevating Pgc‐1฀ levels. The gut microbiome Firmicutes/Bac-
teroidetes ratio decreased with exercise and PEMF exposure, alone or in combination, which has been
associated in published studies with an increase in lean body mass. After 2 months, brief PEMF treatment
alone increased Pgc‐1฀ and mitohormetic gene expression and after >4 months PEMF treatment alone
enhanced oxidative muscle expression, fatty acid oxidation, and reduced insulin levels. Hence, short‐term
PEMF treatment was sufficient to instigate PGC‐1฀‐associated transcriptional cascades governing sys-
temic mitohormetic adaptations, whereas longer‐term PEMF treatment was capable of inducing related
metabolic adaptations independently of exercise.
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Abstract
Exercise modulates metabolism and the gut microbiome. Brief exposure to low mT-
range pulsing electromagnetic fields (PEMFs) was previously shown to accentuate in 
vitro myogenesis and mitochondriogenesis by activating a calcium-mitochondrial axis 
upstream of PGC-1α transcriptional upregulation, recapitulating a genetic response 
implicated in exercise-induced metabolic adaptations. We compared the effects of 
analogous PEMF exposure (1.5 mT, 10 min/week), with and without exercise, on 
systemic metabolism and gut microbiome in four groups of mice: (a) no intervention; 
(b) PEMF treatment; (c) exercise; (d) exercise and PEMF treatment. The combination 
of PEMFs and exercise for 6 weeks enhanced running performance and upregulated 
muscular and adipose Pgc-1α transcript levels, whereas exercise alone was incapable 
of elevating Pgc-1α levels. The gut microbiome Firmicutes/Bacteroidetes ratio de-
creased with exercise and PEMF exposure, alone or in combination, which has been 
associated in published studies with an increase in lean body mass. After 2 months, 
brief PEMF treatment alone increased Pgc-1α and mitohormetic gene expression and 
after >4 months PEMF treatment alone enhanced oxidative muscle expression, fatty 
acid oxidation, and reduced insulin levels. Hence, short-term PEMF treatment was 
sufficient to instigate PGC-1α-associated transcriptional cascades governing sys-
temic mitohormetic adaptations, whereas longer-term PEMF treatment was capable 
of inducing related metabolic adaptations independently of exercise.
K E Y W O R D S
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1 |  INTRODUCTION
The gut microbiome is a dynamic and complex microbial 
community hosted by humans in mutual benefit. The micro-
biome responds to alterations in lifestyle1,2 by modulating 
metabolism,3,4 immunity,5 and overall health.6 Physiological 
status is thus established through a delicate balance of host-
gut microbiota interactions that are influenced by host ge-
netics and age yet, susceptible to perturbations in diet, 
medications, physical activity as well as other environmen-
tal factors.6,7 Previous studies have elucidated evidence of 
bidirectional communication between residing microbial 
communities and the host and have sought to understand its 
underlying mechanisms.8-10
The subtle modulation of host metabolism by the gut 
microbiome was elegantly demonstrated in a recent study 
whereby functional beiging (mitochondrial uncoupled res-
piration) of the inguinal subcutaneous and perigonadal 
visceral adipose deposits of obese mice was promoted 
by depletion of the adiposity-associated gut microbiota.10 
Caloric restriction (CR) also improves metabolism11 and 
can be transmitted to recipient mice with transplantation 
of CR-conditioned microbiome. Whereas, fecal microbiota 
transplant (FMT) from CR mice into obese mice reversed 
hepatic lipid accumulation,9 FMT of CR-microbiota into 
germ-free mice promoted fat browning.8 The microbiome 
is thus capable of adopting both negative and positive as-
pects of host metabolism, that moreover, are subject to 
environmental modulation. The metabolic attributes of 
CR are associated with improvements in muscular mito-
chondrial function mediated by PGC-1α.11 Notably, key 
metabolites produced by the microbial gut communities 
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have been shown to act as signaling/substrate molecules 
that regulate mitochondrial-dependent systemic energy 
balance.12 Hence, evidence suggests that the mitochondria 
and microbiome mutually sustain the function of the other, 
which, in turn, would go toward establishing systemic met-
abolic balance.
Skeletal muscle hosts a large activatable pool of mito-
chondria that impacts systemic metabolism and fatty acid 
oxidation.13-15 In a retrograde manner, germ-free mice lack-
ing a microbiota exhibited muscle atrophy and reduced mi-
tochondrial function.16 FMT from normal mice into these 
germ-free mice recuperated both skeletal muscle mass and 
mitochondrial function. Notably, Pgc-1α and Igf-1 tran-
script levels were reduced in skeletal muscle from these 
germ-free mice and recovered upon FMT from normal 
mice. Recently, the short-chain fatty acids (SCFAs), mi-
crobiome fermentation metabolites, have been found to act 
as agonists for PGC-1α upstream of enhanced mitochon-
driogenesis and free fatty acid oxidation.17-19 The proper 
functioning of this microbiome-mitochondria axis should 
thus support muscle energetics as well as be accentuated 
by exercise.18
Via such a mechanism exercise would prime the gut mi-
crobiome toward metabolic improvement.2,20-22 Oxidative 
muscle would be particularly relevant in this respect as it 
exhibits elevated mitochondrial content23 as well as pre-
dilections for fatty acid oxidation and in supporting in-
sulin-sensitivity.24 Exercise promotes oxidative muscle 
development, whereas inactivity results in oxidative muscle 
atrophy. Oxidative fibers are also characterized by elevated 
resting calcium levels that diminish with inactivity and pre-
cede a reversal in oxidative character.25 In this manner, the 
calcium-permeable channel, Transient Receptor Potential 
Subfamily C Member 1 (TRPC1), is mechanistically linked 
to oxidative muscle development.26,27 TRPC1 expression 
is highest in oxidative muscle fibers28 and wanes with dis-
use.26 Likewise, silencing TRPC1 expression results in ox-
idative muscle loss.26 Calcium entry via TRPC1 activates 
the nuclear factor of activated T-cells (NFAT)26,29 that, in 
turn, sustains TRPC1 expression26,30 as well as those of 
PGC-1α and oxidative muscle.23 Accordingly, NFAT and 
TRPC1 levels decrease upon mechanical unloading and re-
vert upon reloading,26 mirroring decreases and increases 
of oxidative muscle expression, respectively. Ample evi-
dence thus supports cooperative roles for TRPC1, NFAT, 
and PGC-1α in oxidative muscle functional capacity and 
via inference, to microbiome composition via its elevated 
mitochondrial respiratory capacity.
In response to mitochondrial activation via exercise, skel-
etal muscle produces and releases a myriad of cytokines, col-
lectively known as myokines,31 that promote, among other 
responses, the beiging of white adipose tissue (WAT).32,33 In 
turn, “beiged” adipose releases adipokines (aka batokines), 
some of which are in common with the myokine pool, to 
further promote brown adipose recruitment.34 Therefore, 
muscle mitochondrial activation initiates a cytokine cascade 
that ultimately grows to encompass batokines for the rein-
forcement of systemic metabolic balance. Moreover, adipose 
beiging can be transmitted with FMT from fasting-induced 
beiged into microbiome-depleted mice,35 reflecting a form 
of microbiome-muscle/adipose interdependency that could 
potentially be exploited clinically, provided the correct inter-
vention were available.
Motivated by previous studies underscoring the homeo-
static role that muscle mitochondrial activation plays over 
systemic metabolism and gut microbiome, we examined 
whether muscle mitochondrial stimulation employing a 
novel noninvasive magnetic paradigm36 might elicit simi-
lar responses to exercise. We have previously demonstrated 
that brief (10 minutes) exposures to low amplitude (≤2 mT) 
pulsing electromagnetic fields (PEMFs) applied to myo-
blasts or mesenchymal stem cells (MSCs) were necessary 
and sufficient to enhance in vitro myogenesis36 or chondro-
genesis,37 respectively. Importantly, brief PEMF treatment 
was shown to promote in vitro myogenesis by activating a 
TRPC1-mitochondrial axis upstream of enhanced Pgc-1α ex-
pression and mitochondriogenesis.36 Here, we show that this 
same magnetic stimulation paradigm also proved relevant 
for the in vivo scenario. Mice exposed to PEMFs (10 min/
week) for a few months showed increases in oxidative muscle 
development, enhanced fatty acid oxidation, and improved 
insulin-sensitivity. Moreover, 6  weeks of analogous PEMF 
exposure was sufficient to accentuate the metabolic conse-
quences of exercise on muscle and adipose tissues, enhanced 
running performance as well as produced unique shifts in gut 
microbiome communities that are associated with key met-
abolic functions. All effects were correlated with elevated 
Pgc-1α expression levels in muscle and adipose tissues in 
accordance with the installation of systemic mitohormetic 
adaptations.
2 |  MATERIALS AND METHODS
2.1 | Animal studies
2.1.1 | Husbandry and 
institutional clearances
Long-term study
The mouse study was approved by the veterinary author-
ity of the canton Zurich and conducted under license no 
156/2011. All the mice were housed in socially compat-
ible groups under a 12 hours/12 hours light/dark cycle with 
food and water ad libitum. Experimental groups (n  =  6) 
of female C56BL/6J mice (Jackson labs) were subjected 
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to a 6-month regime of PEMF exposure commencing at 
8 weeks of age.
Short-term study
This protocol was approved by the Institutional Animal Care 
and Use Committee (IACUC) of the National University of 
Singapore, and followed the Guide for the Care and Use of 
Laboratory Animals. All experiments were performed on 
8-week-old, female C57BL/6NTac mice, housed individu-
ally, with 12 hours/12 hours light/dark cycles and maintained 
on a standard chow diet.
2.1.2 | PEMF exposure and exercise regimes
The PEMF device used in this study has been previously 
described.36 Succinctly, exposure to 1.5 mT amplitude 
PEMFs for 10 minutes applied once was best suited to pro-
mote in vitro myogenesis. In the present study, an analo-
gous PEMF exposure paradigm was employed on behaving 
mice. Specifically, C56BL/6J mice were exposed once per 
week for a duration of 10 minutes at an amplitude between 
1 and 1.5 mT, unless otherwise indicated. For the short-
term exercise study PEMF exposure at an amplitude of 1.5 
mT was applied to C57BL/6NTac mice once per week on 
Sundays for 10 minutes. Exhaustive running was conducted 
thrice per week, commencing on the following Mondays, 
Wednesdays, and Fridays for six consecutive weeks. Mice 
were sacrificed on week 7.
We adapted the Graded Maximal Exercise Test (GXTm) 
protocol with modification: instead of electrical grid 
shock, we utilized auditory stress to encourage treadmill 
running—paper towels were placed in between the inac-
tivated shock grids such that they would interact with the 
rotating belt of the treadmill and create noise (Columbus 
Instruments, Ohio, USA) while the treadmill was in op-
eration.38 We found that this noise was sufficient to en-
courage the mice to continue running before they reached 
exhaustion.
Prior to the start of the study, mice were acclimatized to 
the treadmill using two walking sessions where they were 
put on a stationary treadmill for 5  minutes, followed by 
10 minutes of walking at 6 m/min. The exercise regime was 
as follows (speed, duration, grade)—(0 m/min, 3 minutes, 
0°), (6  m/min, 2  minutes, 0°), (9  m/min, 2  minutes, 5°), 
(12  m/min, 2  minutes, 10°), (15  m/min, 2  minutes, 15°), 
(18, 21, 23, 24  m/min, 1  minute, 15°), and (+1  m/min, 
each 1 minute thereafter, 15°) until exhaustion. The maxi-
mal speed achieved in every running session was recorded. 
We defined exhaustion as the point at which mice rested 
onthe paper towel for 30 seconds with no further attempt 
to get back on the treadmill, despite persistent auditory 
stimulation.
2.1.3 | Indirect calorimetry
Indirect calorimetry measurements were performed with 
the PhenoMaster (TSE Systems) according to the manu-
facturer's guidelines and protocols. O2 and CO2 levels were 
measured for 60  seconds every 13  minutes continuously 
with PhenoMaster (TSE Systems). Energy expenditure 
was calculated according to the manufacturer's guidelines 
(PhenoMaster Software, TSE System). The respiratory 
quotient was estimated by calculating the ratio of CO2 
production to O2 consumption. Animals were single caged 
and acclimated to the metabolic cages for 48 hours before 
metabolic recording.
2.1.4 | Plasma biochemistry analysis
For long-term PEMF studies (>8 weeks), mice were fasted 
for 6  hours before sacrifice. Blood samples were obtained 
via cardiac puncture, and plasma was collected after cen-
trifugation for 15 minutes at 3000  rpm at 4°C. Cholesterol 
and triglycerides were measured by enzymatic tests (Roche 
Diagnostics). Plasma insulin levels were measured using 
mouse/rat insulin kit (Meso Scale Discovery) as per manu-
facturer’s instructions. Plasma samples for measuring fast-
ing/refeeding NEFAs were obtained after 12 hours of fasting 
and 4 hours of refeeding, using NEFAs kit (WAKO).
For the short-term studies, plasma was centrifuged for 
10 minutes at 10 200  rpm at 4°C. For quantitative deter-
mination of plasma IL-6, insulin, leptin, adiponectin, and 
VEGFA evaluated by magnetic bead-based multiplex assay 
was performed using Bio-Plex Pro Mouse Cytokine 23-
Plex Assay and Bio-Plex Pro Mouse Diabetes Adiponectin 
Assay (Bio-Rad, USA). The results were read using Bio-
Rad 200 System microplate photometer (Bio-Rad, USA) 
and read using Bio-Plex Manager software (Bio-Rad, 
USA). IL-6, insulin, leptin, and adiponectin concentrations 
were determined using a standard curve (determined dy-
namic range of 0.74-12  053  pg/mL, 93.4-47  815  pg/mL, 
17.1-69 900 pg/mL, and 38.0-62 043 pg/mL, respectively) 
according to manufacturer's instructions.
2.1.5 | Muscle histology
Mice were euthanized by CO2 inhalation and the gastrocne-
mius and soleus muscles dissected, fixed with 4% of formal-
dehyde, dehydrated and embedded in paraffin for oxidative 
(fast) or glycolytic (fast) muscle fiber detection. The paraf-
fin sections were stained with the NCL-MHCf monoclonal 
antibody (Novocastra) to detect slow myosin heavy chain. 
Images were analyzed using ImageJ (public domain, National 
Institutes of Health, USA).
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2.1.6 | Adipose tissue isolation
Following CO2 euthanization, interscapular brown and 
subcutaneous white inguinal adipose samples were har-
vested and immediately snap frozen in liquid nitrogen. For 
genetic analysis, frozen samples were pulverized and their 
total RNAs extracted for downstream quantitative PCR 
experiment.
2.1.7 | Primary adipocyte isolation and 
adipocyte differentiation
Inguinal adipose harvested from 3- to 4-week-old C57BL/6J 
mice were washed, minced, and then, digested for 25 min-
utes at 37°C with brief intermittent vortex every 5 minutes 
in collagenase (0.2%, Sigma). Digestion was stopped with 
DMEM and dissociated cells were filtered through a 100 mm 
strainer. Isolated SVF cells were spun down by centrifugation 
at 1000 rpm for 5 minutes, and then, resuspended for plat-
ing in DMEM containing 10% of fetal bovine serum (FBS, 
Invitrogen), 50 units/mL of penicillin, 50  mg/mL of strep-
tomycin, and 10 mg/mL of gentamicin (Invitrogen) at 10% 
CO2 at 37°C. For adipocyte differentiation, confluent cul-
tures were exposed to an adipogenic cocktail supplemented 
with dexamethasone (0.5  mM, Sigma), insulin (0.85  mM, 
Sigma), isobutylmethylxanthine (250  mM, Sigma), rosigli-
tazone (1  mM, Sigma) in DMEM containing 10% of FBS 
for 48  hours. Otherwise, cells were maintained in DMEM 
containing 10% of FBS.
2.2 | Gut microbiome profiles
2.2.1 | Microbiome sampling of stool
At termination, mice were euthanized by CO2 asphyxia-
tion and their ceca, and wet fecal matter contained therein 
were immediately snap frozen in liquid nitrogen and stored 
at –80°C until further analysis. Cecal and fecal samples 
were thawed, weighed, and total bacterial DNA was ex-
tracted using the DNeasy PowerSoil Kit (Qiagen, Hilden, 
Germany) according to manufacturer's instructions. Total 
yield and purity of DNA were measured using a NanoDrop 
One Spectrophotometer (Thermo Scientific, Delaware, 
USA).
2.2.2 | Microbiome profiling of 
stool samples
Three mice were selected from each treatment group: No 
exercise and no PEMF treatment (–E/–P); No exercise plus 
PEMF treatment (–E/+P); Exercise and no PEMF treatment 
(+E/–P); Exercise plus PEMF treatment (+E/+P) to deter-
mine microbial community composition of cecal and fecal 
samples of mice belonging to the different treatment groups 
(Figure S1). This was achieved by 16S rRNA gene ampli-
con sequencing targeting the V4 region of bacterial 16S 
rRNA genes using 515F (5ʹ-GTGCCAGCMGCCGCGG-3ʹ) 
and 907R (5ʹ-CCGTCAATTCMTTTRAGTTT-3ʹ) primers. 
Samples were sequencing on the Illumina MiSeq platform 
at the Argonne sequencing core (Chicago, USA). Sequenced 
data were processed using the QIIME39 pipeline where reads 
were trimmed, quality checked, and aligned to the Green 
Genes database, clustered at 97% similarity into Operational 
taxonomic units (OTUs) and annotated against the SILVA ri-
bosomal RNA database. Sequence reads were deposited into 
the NCBI Sequence read archive (SRA) under the BioProject 
number PRJNA482925. Linear discriminant analysis effect 
size (LEfSe), was used to determine statistically significant 
OTUs which contributed to differences between the treat-
ment groups.40
2.2.3 | Predictive pathways of the 
gut microbiota
A.biome file was created using QIIME and analyzed using 
the bioinformatics software PICRUSt to predict the func-
tional composition of the gut microbial community from the 
16S rRNA gene profile and LefSe was used to identify sta-
tistically significant biological pathways which defined each 
treatment group.41
2.3 | Muscle and tissue gene 
expression profiles
2.3.1 | qPCR
Quantitative Reverse-Transcription Polymerase Chain 
Reaction (RT-qPCR) was carried out on muscle and adi-
pose tissue samples with TaqMan or SYBR green-based 
detection workflow. The list of qPCR primers can be found 
in Table 1.
2.3.2 | Mouse muscle samples, TaqMan-
based workflow
The soleus and extensor digitorum longus (EDL) muscles of 
mice were harvested at study termination, washed in PBS, snap 
frozen in liquid nitrogen, and stored at –80°C. Total RNAs were 
then extracted by TRIzol reagent (Thermo Scientific) and qual-
ity assessed using the Agilent 2200 Tape station system and 
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T A B L E  1  List of qPCR Primers in muscle and adipose tissues




























Sod2 TCTGTGGGAGTCCAAGGT TC TAAGGCCTGTTGTTCCTTGC
Gene Company Cat no
Muscle tissue (TaqMan probe)
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the Agilent Bioanalyzer 2100 (Agilent, Waldbronn, Germany). 
Following treatment with TURBO DNase (Thermo Scientific), 
equal amounts of RNA from each animal per treatment group 
(n = 8) were combined and reverse transcribed using Superscript 
II (Thermo Scientific). Alternatively, when sufficient total 
RNAs were obtained from each animal, they were reverse 
transcribed as separate biological replicates. Quantification of 
mRNA expression levels in each sample was performed with 
TaqMan Gene Expression Assays (Thermo  Scientific) using 
the StepOnePlus Real-Time PCR System (Life Technologies). 
All values were normalized to Mrps12 (Mm00488728_m1) and 
presented as fold-changes. Each 10 μL reaction consisted of 1X 
TaqMan Fast Universal PCR Master Mix (Life Technologies), 
1X TaqMan Gene Expression Assay and 10 ng cDNA. All re-
actions were performed in fast optical 96-well reaction plates 
(Life Technologies) at 95°C for 20 seconds and 40 cycles of 
95°C for 1 second and 60°C for 20 seconds.
2.3.3 | Mouse muscle samples, SYBR green-
based workflow
Tissue harvest, preservation, and total RNAs extraction were 
as in TaqMan-based workflow above. Reverse transcription 
of total RNAs was carried out using the iScript cDNA syn-
thesis kit (Bio-Rad) and gene expression levels were ana-
lyzed with Sso advanced Universal SYBR Green Supermix 
(Bio-Rad). Each 10 μL reaction consisted of 1X SYBR green 
mix, 100 - 150 nM of forward and reverse primers, and 10 ng 
cDNA. Amplification parameters were: 1 cycle of enzyme 
activation step (1x, 95°C, 5 minutes), 40 cycles of denatura-
tion (95°C, 10  seconds), and annealing/extension (primer-
specific temperature 55°C-60°C, 30 seconds) steps, followed 
by 1 cycle of melt curve(95°C for 15  seconds, annealing 
temperature for 1 minute and ramp up to 95°C in increments 
of 0.5°C) and cooling at 10°C. B2m was amplified at 55°C, 
Pgc-1α at 57°C, Sirt1 at 58°C, and all other primers at 60°C. 
All transcripts were normalized to B2m.
2.3.4 | Mouse adipose samples, SYBR green-
based workflow
Mouse adipose samples were homogenized using Magna 
Lyser machine and ZIRCONIA beads. Total RNA was iso-
lated using easy-BLUE (TM). Total RNA  extraction and 
clean-up was conducted using QIAGEN RNeasy Mini kit. 
cDNA was generated using M-MLV reverse transcriptase 
kit and random hexamers (both from Invitrogen). Real-time 
PCR was performed using Applied Biosystems ViiA7 and 
SensiFAST SYBR Hi-ROX kit (Bioline). All transcripts 
were normalized to Rpl23. PCR conditions used were 50°C 
for 2 minutes, 95°C for 10 minutes, followed by 40 cycles 
of 95°C for 15 seconds and 60°C for 1 minute. Experiments 
were done with at least five independent samples and three 
technical replicates per sample. Relative gene expression was 
presented as ∆∆Ct.
2.4 | Statistical analysis
The statistical software package PRIMER–E version 742 was 
used to analyze similarities in cecal and fecal microbiota 
composition between different treatment groups. Briefly, 
the OTU abundance data generated by QIIME was normal-
ized using a log (x  +  1) transformation and the distance 
matrices between treatment groups were calculated using a 
Bray-Curtis analysis and presented as a Principal Coordinate 
Analysis (PCO). A permutational multivariate analysis of 
variance (PERMANOVA) test was used to verify if micro-
bial compositions between the treatment groups were signifi-
cant, and a pairwise PERMANOVA test was used to validate 
difference between two groups.
For the analysis of gene expression, a two-way ANOVA 
test was used to determine significant differences in mus-
cle and adipose tissues in response to distinct interventions. 
Statistical estimation plots were also applied to our short-term 
(6 weeks) mouse study to estimate effect size and uncertainty.43  
The Δ values in these plots represent the difference of means 
between the control and experimental group where the effect 
size is denoted by the black dot in the Δ value panels and 
the uncertainty of the estimate is shown by the gray-colored 
violin plot. The black line passing through the black dot de-
notes 95% confidence interval of the estimates. If the line 
does not cross zero (gray horizontal line), it is an equivalent 
finding to having a P value of .05, or better. Additionally, a 
pairwise Student's t test was conducted for each experimen-
tal condition relative to its correspondent control scenario (0 
mT, non-exercised; (–E/–P) and is indicated in each plot by 
red ** or * to denote P < .01 and < .05, respectively.
3 |  RESULTS
3.1 | Brief, weekly PEMF exposure 
enhances oxidative muscle development in mice
We previously reported that extremely low frequency and 
low amplitude PEMFs applied once for 10 minutes promoted 
in vitro myogenesis by activating a TRPC-mitochondrial 
axis upstream of PGC-1α activation,36 the same genetic re-
sponse previously implicated in exercise-enhanced oxidative 
muscle development.23-30 Here, we tested the efficacy of an 
analogous PEMF exposure paradigm on mice. Mice were 
exposed to either 0 (sham controls), 0.5, 1, or 2 mT ampli-
tude PEMFs for 10 minutes per week for 6 months, followed 
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by examination of the Soleus, a predominantly oxidative 
muscle. The cross-sectional area of oxidative muscle fibers 
decreased in PEMF-treated mice (Figure  1A), representing 
a known metabolic adaptation44 aimed at facilitating oxy-
gen uptake into oxidative fibers with heightened mitochon-
drial respiratory capacities and linked to the expressions of 
PGC-1α44 and myogenin.45 This effect became apparent at 
1 mT applied once, rather than thrice, weekly (Supplemental 
Figure S2), recapitulating a similar sensitivity as delineated 
in vitro.36 By contrast, the cross-sectional area of glycolytic 
fibers was unchanged by PEMF treatment (Figure 1A, inset). 
These results demonstrate that brief weekly PEMF treatment 
promotes functional adaptations in oxidative muscle in vivo. 
From here onward, all data relating to PEMF exposure will 
be depicted in blue and their correspondent control scenarios 
(0 mT) in red.
F I G U R E  1  Weekly PEMF exposure enhances oxidative muscle capacity in mice. A, Cross-sectional area of oxidative muscle fibers following 
PEMF treatment; 0 mT (n = 279 fibers), 0.5 mT (n = 240), 1 mT (n = 635), 2 mT (n = 954) (see Supplemental Figure S2). Inset) Glycolytic 
fibers cross-sectional area from exposed (blue; n = 312) or control (red; n = 178) mice; (a.u. (×103)). B, Solei muscles stained for slow myosin 
heavy chain. Scale bar = 500 μm. C, NFAT-regulated gene expression from calf musculature of mice exposed once/week. D, Indirect calometric 
measurement of respiratory exchange ratio (RER). E, Serum markers after 4 months of weekly PEMF exposure (also see Figure S7). All PEMF 
exposures were for 10 minutes. Panels A, B, D represent data generated from female mouse cohorts of 6 mice/condition. Panels C and E represent 
data generated from 8 to 16 female mice/condition, respectively. PEMF treatment (2 mT) was for 4 (C-E) or 6 months (A,B) without additional 
exercise. ** and *P < .01 and < .05, respectively, wrt correspondent 0 mT.
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Transcripts for the NFAT-regulated genes, Trp1,30 
Pgc-1α,23,46 and Myog (myogenin)47 were previously shown 
to be upregulated by PEMF exposure promoting in vitro 
myogenesis.36 Analogously, transcripts for Trpc1, Pgc-1α, 
Myog as well as Igf148 were shown to increase in the leg mus-
culature of PEMF-treated mice (Figure  1C), corroborating 
NFAT/calcineurin-mediated oxidative muscle enhancement 
in vivo,23,26-29 and demonstrating genetic and developmental 
F I G U R E  2  PEMF treatment accentuates the effects of weekly exercise in mice. A, Running performance in mice ran to exhaustion thrice/
week and exposed to PEMFs (1.5 mT) once/week. Shown is the running performance during the third trial of each indicated week (see Methods). 
Serum leptin (B) and insulin (C) levels of the indicated experimental groups after 6 weeks of treatment. Pgc-1α transcript levels in our four 
indicated intervention groups in the Soleus (D) and EDL (E) muscles analyzed by two-way ANOVA (see Table 2 for details). Statistical estimation 
plots43 for Mef2c for the Solei (F) and EDL muscles (G) under our four experimental conditions. The ∆ values represent the difference of means 
between the control and experimental groups, the effect size is denoted by a black dot in the ∆ value panels and the uncertainty of the estimate is 
shown by the gray-colored violin plot. The black line passing through the black dot denotes 95% confidence interval of the estimates. If the line 
does not cross zero (gray horizontal line), it is an equivalent finding to having P value .05, or better (also see Figure S3). All PEMF exposures 
were for 10 minutes. All means are derived from six female mice/condition. ** and *P < .01 and < .05, respectively, relative to the indicated 
experimental group.
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symmetry with previous in vitro findings.36 Myogenin coop-
erates with NFAT and TRPC1 to enhance oxidative muscle 
capacity47,49 and positively correlates with mitochondrial 
respiratory capacity in oxidative fibers.45 IGF-1 is a myo-
kine promoting muscle regeneration, whose expression is 
greatest in highly oxidative fibers.44 The transcript levels of 
Cd36 (mitochondrial fatty acid translocase; FAT) were also 
increased with PEMF treatment (Figure 1C), aligning with 
previously described PGC-1α-stimulated mitochondrial fatty 
acid uptake and mitochondriogenesis,50 enhancing systemic 
fatty acid oxidation and insulin-sensitivity.51 Accordingly, 
the resting respiratory exchange ratio (RER), a described 
metabolic adaptation to PGC-1α upregulation,52 commenced 
to drop 5  weeks after commencement of PEMF treatment, 
corroborating PGC-1α-dependent enhancement of fatty acid 
oxidation as a result of our magnetic paradigm (Figure 1D). 
Serum insulin levels were also reduced by PEMF treatment 
(Figure  1E), paralleling accepted exercise-induced adapta-
tions including enhanced oxidative muscle expression, fatty 
acid oxidation, and insulin-sensitivity.51,53 Weekly PEMF 
treatment (10  min/week) for a few months hence recapitu-
lates key aspects of the systemic benefits typically associated 
with exercise.51
3.2 | Short-term weekly PEMF treatment 
potentiates the effects of exercise
Endurance exercise increased muscular PGC-1α expres-
sion51 to a comparable degree as weekly PEMFtreatment 
T A B L E  2  Myogenic gene modulation by weekly PEMF intervention. Gene expression following 6 weeks of PEMF/exercise intervention in 




Two-way ANOVA P values
0 mT 1.5 mT 0 mT 1.5 mT
Group 1 Group 2 Group 3 Group 4
–E/–P –E/+P +E/–P +E/+P
Mean (SD)
PEMF vs no 
PEMF





Soleus Pgc-1α 0.72 (0.32) 1.00 (0.44) 0.74 (0.67) 1.56 (0.74) 0.03 0.25 0.28
P = .03 wrt 1
P = .02 wrt 3
Cpt1b 0.77 (0.57) 1.73 (1.22) 1.4 (0.92) 2.36 (2.00) 0.10 0.27 1.00
Nampt 0.90 (0.53) 1.39 (0.78) 1.07 (0.6) 2.01 (1.75) 0.12 0.38 0.62
Sirt1 0.60 (0.25) 2.08 (1.17) 2.20 (1.84) 2.37 (1.85) 0.22 0.17 0.33
Vegf-a 0.84 (0.30) 1.91 (1.00) 1.58 (1.29) 1.35 (1.09) 0.34 0.84 0.14
Mef2c 0.83 (0.59) 1.78 (0.81) 1.28 (0.95) 1.7 (1.19) 0.11 0.65 0.52
Fndc5 0.74 (0.39) 1.37 (0.93) 1.51 (0.86) 1.55 (0.93) 0.35 0.19 0.40
Trim55 0.8 (0.61) 1.61 (2.0) 1.81 (1.33) 2.52 (2.63) 0.34 0.23 0.95
Gasp1 0.88 (0.32) 2.34 (2.03) 1.40 (0.90) 1.09 (1.30) 0.31 0.52 0.13
EDL Pgc-1α 1.02 (0.69) 3.35 (3.58) 1.78 (1.12) 1.90 (2.66) 0.29 0.76 0.34
Cpt1b 0.93 (0.61) 3.59 (4.18) 1.54 (1.31) 1.84 (2.46) 0.25 0.65 0.35
Nampt 0.99 (0.51) 2.47 (1.93) 1.90 (1.46) 1.70 (1.91) 0.40 0.93 0.27
Sirt1 1.01 (0.92) 2.30 (2.74) 1.18 (1.17) 1.54 (1.90) 0.36 0.74 0.60
Vegf-a 0.96 (0.44) 0.94 (0.48) 0.73 (0.32) 1.03 (0.57) 0.51 0.76 0.47
Mef2c 0.83 (0.42) 2.94 (5.06) 1.24 (0.70) 2.01 (2.06) 0.31 0.85 0.63
Trim55 1.75 (1.98) 1.43 (1.54) 0.54 (0.22) 1.07 (1.36) 0.87 0.22 0.51
Gasp1 1.08 (0.48) 3.55 (3.80) 1.28 (1.10) 1.68 (0.88) 0.18 0.42 0.32
Note: The left side of the table shows the mean and standard deviation of gene expression levels in each group. The right side of the table shows the P values from two-
way analysis of variance analyses to test the effects of PEMF and exercise, and the statistical interaction between the two. The P values in bold indicate the P values 
from the test of differential expression between one group in the column with regards to (wrt) another group, using Tukey's test for multiple pairwise comparisons.
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(Figure 1C), suggesting a correlation between exercise and 
PEMF exposure. Given that systemic fatty acid oxidation 
commenced to increase (reduced RER) 5 weeks after com-
mencing PEMF treatment (Figure  1D), we examined the 
combined effects of short-term PEMF treatment, alone or 
combined with exhaustive exercise. Mice were ran to ex-
haustion thrice weekly in conjunction with weekly PEMF 
exposure (1.5 mT for 10 minutes). After 5 weeks of exhaus-
tive running, mice undergoing PEMF treatment (blue) com-
menced to out-perform control counterparts (red; Figure 2A); 
that moreover, commenced to show signs of overtrain-
ing at 5  weeks. Notably, strenuous exercise raised leptin 
(Figure 2B) and insulin (Figure 2C) levels that were normal-
ized with concomitant PEMF treatment. These results agree 
with data demonstrating stress induces elevations in serum 
leptin levels,54 a response that appeared to be ameliorated in 
response to PEMF treatment.
The Soleus and EDL represent muscles of the leg charac-
terized by high and low oxidative capacities, respectively.25 
Two-way ANOVA statistical analyses detected significant 
F I G U R E  3  PEMF treatment accentuates adipose browning and insulin-sensitivity in response to exercise. Ucp1 transcript levels increased 
in inguinal white adipose tissue (A; WAT), but not interscapular brown adipose tissue (B; BAT), following 6 weeks PEMF intervention (10 min/
week) in conjunction with exhaustive exercise. Cox7a1 transcript levels increased in WAT (C), but not BAT (D), following weekly PEMF 
intervention and exhaustive exercise interventions. Irs1 transcript levels increased in both WAT (E) and BAT (F) following weekly PEMF 
intervention and exhaustive exercise interventions, but only in WAT by exercise alone (E). Cebp-α gene expression was increased in WAT (G) 
and BAT (H) by exercise with and without PEMF treatment. All means are derived from six female mice/condition. ** and *P < .01 and < .05, 
respectively, wrt correspondent 0 mT (non-exercised) and ## and # P < .01 and < .05, respectively, wrt correspondent 1.5 mT (non-exercised) by 
two-way ANOVA. See Table 3 for further details. Mice were exposed to PEMFs for 10 min/week for 6 weeks.
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increases in Pgc-1α gene expressions in Solei of the PEMF 
plus exercise (+E/+P) cohort, compared to the unexercised 
(–E/–P) or exercised (+E/–P) cohorts, but not from PEMF-
treated mice (–E/+P), reflecting a significant interaction 
with PEMF treatment (Table 2). On the contrary, significant 
changes in gene expression in the EDL were not achieved 
in any of the cohorts. Statistically significant elevations in 
Pgc-1α expression preceded that of the other Solei genes at 
6  weeks. Paired t tests of the distinct intervention cohorts 
against the control cohorts (–E/–P) corroborated increases in 
Pgc-1α in the dual intervention cohort of mice (+E/+P) for 
Solei (Figures  2D, S3A), but not EDL (Figures  2E, S3B), 
as well as revealed a general trend for genes associated with 
PGC-1α (Sirt1, Mef2c), oxidative muscle expression (Vegf-a, 
Nampt, Trim55, Gasp1), or fat metabolism (Cpt1β, Fndc5) 
(Supplemental Figure S3), whereby PEMF treatment alone 
(–E/+P) raised gene expression in the Soleus over control lev-
els (–E/–P), often approaching or surpassing that of the exer-
cise alone (+E/–P) or exercise plus PEMF treatment (+E/+P) 
groups. Notably, statistical significance was observed for the 
Solei genes, Sirt1, Mef2c, and Vegf-a, in the PEMF-treated 
alone (–E/+P) cohort relative to controls (–E/–P), whereas 
exercised mice, with (+E/+P) or without (+E/–P) PEMF 
treatment, were not statistically different from sham controls 
(–E/–P). MEF2C promotes PGC-1α expression23,46,55-57 and 
correlates with NFATC1 expression pattern36,58 that precedes 
and predicts oxidative muscle development.59 SIRT1 stimu-
lates PGC-1α expression, upstream of mitochondriogenesis 
and metabolic balance.11 VEGFA is an angiogenic myok-
ine upregulated by PGC-1α and exercise.60,61 Mef2c, Sirt1, 
and Vegf-a were all upregulated by PEMF treatment alone 
(–E/+P) in Solei (Figures 2F, S3C,E, respectively), but not 
EDL (Figures 2G, S3D,F, respectively). Therefore, 60 min-
utes of total PEMF exposure (distributed over 6 weeks) was 
sufficient to upregulate the expression of mitochondrial genes 
associated with PGC-1α (Mef2c and Sirt1), whereas genes 
related to muscle hypertrophy (Gasp1 and Trim55) or meta-
bolic adaptations (Nampt, Cpt1β, and Fndc5) exhibited only 
nonsignificant elevations at 6  weeks in response to PEMF 
exposure, with or without exhaustive exercise.
3.3 | Adipogenic consequences of short-term 
weekly PEMF treatment and exercise
The adipogenic consequences of short-term PEMF treat-
ment in combination with exercise (+E/+P) were relatively 
strong compared to those of skeletal muscle. Nonetheless, di-
rect PEMF exposure had little effect over thermogenic gene 
expression in isolated adipocytes derived from either WAT 
or BAT deposits (Supplemental Figure S4), suggesting that 
the in vivo adipose tissue-specific effects arose from muscle, 
presumably via the secretion of myokines,31-33,62,63 such as 
IGF-1 (Figure 1C) and VEGFA (Figure S3E), and aligning 
with the fact that the observed changes were induced by ex-
ercise that directly recruits the activity of muscle.
Adipose samples from the combined PEMF-treated and 
exercised cohort (+E/+P) showed greater elevations of Ucp1 
and Cox7a1 in WAT (subcutaneous inguinal) (Figure 3A,C), 
respectively, than in BAT (interscapular) (Figure  3B,D; 
Table  3), respectively, reflecting the involvement of these 
genes in white adipose browning, mitochondriogenesis and 
lipid oxidation,64 and paralleling previously demonstrated 
disparate exercise-induced thermogenic responses of the 
inguinal (WAT) vs interscapular (BAT) adipose deposits.65 
Pgc-1α expression was significantly elevated in both WAT 
and BAT by the combination of exercise and PEMF treat-
ment (+E/+P) relative to sham control (–E/–P) and exer-
cised alone (+E/–P) groups, but not from the PEMF alone 
cohort (–E/+P) (Table 3), recapitulating the same Pgc-1α-
PEMF interaction detected in the Soleus muscle (Table 2; 
Figures 3D, S3A). The expression levels of the insulin re-
ceptor substrate 1 (Irs1) gene, mediator of insulin, and IGF 
signaling pathways,66 was upregulated in WAT by exercise 
alone (+E/–P) (Figure 3E) and in WAT and BAT by com-
bined exercise and PEMF treatment (+E/+P) (Figure 3E,F, 
respectively), corroborating that beiged WAT (Figure 3A,C) 
induced by PEMF exposure, exhibits greater insulin-sensitiv-
ity.67 Cebp-α expression was elevated by both exercise alone 
(+E/–P) and in combination with PEMF treatment (+E/+P) 
in both WAT (Figure 3G) and BAT (Figure 3H), reflecting 
its reported positive association with insulin-sensitivity and 
negative relationship to adipose mass.68 Glut4 (Slc2a4) gene 
expression was elevated by exercise alone (+E/–P) in both 
WAT and BAT and further augmented by supplemental 
PEMF treatment (+E/+P) only in WAT (Table 3), parallel-
ing findings that exercise either enhances or suppresses glu-
cose uptake in WAT and BAT, respectively.69 Provocatively, 
the inhibition of insulin-mediated glucose uptake into BAT 
by exercise has been previously shown to be inversely cor-
related with inflammatory status.69 Notably, our exhaustive 
exercise paradigm (+E/–P) raised leptin (Lep) transcript 
levels in WAT and BAT that were normalized in WAT 
with the addition of PEMF treatment (+E/+P) (Table  3), 
as previously shown serologically from these same mice 
(Figure  2B). Finally, nicotinamide phosphoribosyltransfer-
ase (Nampt) gene expression was enhanced in BAT, but not 
WAT, by the combination of exercise and PEMF treatment 
(+E/+P) (Table 3), underlying its positive correlation to in-
sulin-sensitivity, adiponectin levels, fatty acid oxidation, and 
PPAR signaling.70 Therefore, short-term (6 weeks) weekly 
(10  min/week) PEMF treatment of mice was sufficient to 
accentuate the onset of known physical (Figure 2) and met-
abolic (Figures 1-3) adaptations commonly associated with 
exercise that previously have been positively correlated with 
PGC-1α expression.
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T A B L E  3  Systemic adipogenic modulation by weekly PEMF intervention. Gene expression following 6 weeks of PEMF/exercise intervention 
in brown (interscapular) and white (subcutaneous inguinal) adipose samples
Genes
Sedentary Exercise
Two-way ANOVA P values
0 mT 1.5 mT 0 mT 1.5 mT
Group 1 Group 2 Group 3 Group 4




Exercise vs no 
exercise
PEMF & exercise 
interaction
White adipose tissue
Pgc-1α 0.56 (0.24) 0.80 (0.25) 0.53 (0.18) 1.06 (0.35) 0.002 0.30 0.18
P = .004 wrt 1
P = .002 wrt 3
Ucp1 0.51 (0.60) 1.51 (2.62) 5.3 (4.28) 8.32 (8.02) 0.32 0.01 0.61
P = .01 wrt 1
P = .03 wrt 2




Glut4 1.07 (0.46) 1.27 (0.69) 2.14 (1.03) 2.64 (0.53) 0.23 <0.001 0.61
P = .02 wrt 1 P = .001 wrt 1
P = .05 wrt 2 P = .003 wrt 2
Irs1 1.03 (0.29) 1.09 (0.5) 1.65 (0.32) 1.98 (0.41) 0.23 <0.001 0.40
P = .01 wrt 1 P < .001 wrt 1
P = .02 wrt2 P = .001 wrt 2
Lep 0.65 (0.27) 0.48 (0.28) 1.20 (0.62) 0.88 (0.41) 0.18 0.01 0.66
P = .03 wrt 1
P = .01 wrt 2
Nampt 1.05 (0.22) 0.99 (0.51) 0.98 (0.4) 1.55 (0.34) 0.15 0.16 0.08
Cebp-α 1.03 (0.26) 1.01 (0.46) 1.88 (0.80) 2.17 (0.79) 0.60 0.001 0.56
P = .03 wrt 1 P = .005 wrt 1
P = .03 wrt 2 P = .004 wrt 2
Fasn 1.83 (1.6) 4.60 (3.58) 2.20 (1.51) 4.21 (2.55) 0.03 0.99 0.72
AdipoQ 1.01 (0.11) 1.09 (0.40) 0.98 (0.41) 1.08 (0.53) 0.56 0.92 0.96
Prdm16 0.70 (0.22) 1.09 (0.58) 0.83 (0.40) 1.01 (0.36) 0.10 0.88 0.54
Elovl3 6.04 (7.83) 10.37 (10.51) 2.71 (1.72) 7.71 (5.98) 0.13 0.32 0.91
Dio2 1.72 (1.53) 2.63 (2.00) 1.38 (0.32) 3.00 (2.64) 0.13 0.99 0.67
Brown adipose tissue
Pgc-1α 1.14 (0.62) 1.88 (0.99) 1.06 (0.61) 2.58 (1.80) 0.02 0.50 0.40
P = .04 wrt 1
P = .03 wrt 3
Ucp1 1.15 (0.71) 1.37 (1.4) 2.37 (1.52) 3.35 (2.44) 0.39 0.03 0.58
P = .03 wrt 1
Cox7a1 0.84 (0.14) 0.67 (0.20) 0.74 (0.13) 0.74 (0.08) 0.18 0.78 0.17
(Continues)
11156 |   TAI ET AL.
3.4 | Systemic mitohormetic responses to 
PEMF treatment
Given that mice commenced to show signs of duress after 
6 weeks of thrice weekly exhaustive exercise (Figure 1), an-
other study was undertaken to examine the combined effects 
of PEMF exposure and more moderate exercise, twice weekly, 
conducted for 8 weeks. By contrast with 6 weeks of treatment 
where PEMF exposure alone (–E/+P) produced significant 
upregulations in only a subset of genes, 8 weeks of exposure 
was sufficient to detect significant changes in the expression 
for all candidate genes involved in systemic mitohormetic ad-
aptations (Figure 4; cf Figure S3). PGC-1α is a master regula-
tor of mitochondriogenesis, subject to regulation by SIRT1,11 
and is responsible for initiating skeletal muscle mitohormetic 
adaptations to endurance exercise.71 PGC-1α-mediated mi-
tohormetic adaptations occur through interactions with other 
transcription factors including myocyte enhancer factor-2 
(MEF2C), peroxisome proliferator-activated receptor-α 
(PPAR-α), and nuclear respiratory factors 1 and 2 (NRF1/2).57 
Mitochondrial transcription factor A (TFAM) regulates mi-
tochondriogenesis resulting from this same transcriptional 
cascade,57,72 downstream of superoxide dismutase 2 (SOD2) 
upregulation, also strongly implicated in systemic mito-
hormesis.72,73 Transcription factor EB (TFEB) regulates ex-
ercise-mediated muscle mitochondriogenesis and establishes 
metabolic flexibility,15 including enhanced fatty acid oxida-
tion (Figure 1D), in coordination with PGC-1α activation.74 
Finally, NAD(P)H dehydrogenase [quinone] 1 gene (NQO1) 
is a participant of the PGC-1α-NRF2 transcriptional cas-
cade that governs mitohormetic adaptation against oxidative 
stress.73,75,76 Significant upregulations in the expression of 
these genes were consistently observed in response to PEMF 
treatment alone (–E/+P), and less often with exercise alone 
(+E/–P) or combination treatment (+E/+P) (Figure 4A-J). 
The sum of these data indicate that PEMFs instill PGC-1α-
associated mitohormetic adaptations in vivo, paralleling our 
previous in vitro findings.36
Genes
Sedentary Exercise
Two-way ANOVA P values
0 mT 1.5 mT 0 mT 1.5 mT
Group 1 Group 2 Group 3 Group 4




Exercise vs no 
exercise
PEMF & exercise 
interaction
Glut4 1.08 (0.42) 1.06 (0.33) 1.99 (0.86) 1.65 (0.46) 0.433 0.003 0.487
P = .01 wrt 1
P = .01 wrt 2
Irs1 1.06 (0.37) 1.18 (0.34) 1.62 (0.72) 1.99 (0.75) 0.31 0.009 0.60
P = .01 wrt 1
P = .02 wrt 2
Lep 1.17 (0.67) 1.02 (0.79) 2.02 (0.76) 0.73 (0.41) 0.02 0.32 0.05
P = .041 wrt 1 P = .004 wrt 3
P = .019 wrt 2
Nampt 6.65 (1.06) 4.83 (1.49) 6.96 (2.38) 9.02 (3.86) 0.91 0.04 0.07
P = .01 wrt 2
Cebp-α 1.02 (0.21) 0.96 (0.14) 1.37 (0.24) 1.38 (0.18) 0.7809 <0.001 0.6781
P = .006 wrt 1 P = .005 wrt 1
P = .002 wrt 2 P = .002 wrt 2
Fasn 0.80 (0.31) 0.89 (0.23) 0.77 (0.31) 0.77 (0.40) 0.73 0.55 0.75
AdipoQ 1.04 (0.17) 1.08 (0.25) 0.98 (0.23) 1.11 (0.26) 0.37 0.89 0.59
Prdm16 0.81 (0.26) 0.77 (0.42) 0.70 (0.32) 0.98 (0.22) 0.37 0.71 0.22
Elovl3 1.03 (0.38) 1.40 (0.64) 1.22 (0.58) 1.37 (0.62) 0.27 0.73 0.63
Dio2 1.27 (0.72) 1.52 (1.26) 1.40 (1.04) 3.53 (2.86) 0.10 0.14 0.19
Note: The left side of the table shows the mean and standard deviation of gene expression levels in each group. The right side of the table shows the P values from two-
way analysis of variance analyses to test the effects of PEMF and exercise, and the statistical interaction between the two. The P values in bold indicate the P values 
from the test of differential expression between one group in the column with regards to (wrt) another group, using Tukey's test for multiple pairwise comparisons.
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PGC-1α activation has been shown to stimulate free fatty 
acid oxidation and myokine production,77 associated with 
mitochondrial upregulation.31,78 Insulin levels incrementally 
decreased between treatment groups, ultimately reaching sig-
nificance for the dual PEMF-treated and exercised cohort 
(+E/+P) at 8 weeks (Figure 4K). Accordingly, adiponectin, a 
myokine/adipokine with insulin-sensitizing attributes,79 rose 
incrementally between ascending groups until reaching sig-
nificance in the dual intervention cohort (+E/+P) (Figure 4L). 
Adiponectin levels have been shown to positively correlate with 
adipose PGC-1α and UCP1 levels,24 giving a greater context 
to these adiponectin results and adipose transcript analyses per 
condition (Figure 3 and Table 3). The levels of interleukin-6 
(IL-6), the prototypical myokine,62,63 showed a tendency to rise 
in response to 8 weeks of PEMF treatment alone (–E/+P), but 
failed to reach statistical significance (Figure 4M). Serum leptin 
(adipokine) levels are known to be lowered by exercise train-
ing (≥ 2 weeks) and positively correlate with obesity and sys-
temic inflammation.80 Leptin levels were found to drop in mice 
treated with PEMFs alone (–E/+P) (Figure 4N). VEGFA is a 
pro-angiogenic myokine upregulated by PGC-1α in response to 
exercise60,61 and notably, was the only gene, not directly related 
to mitochondriogenesis, upregulated at 6 weeks in response to 
PEMF exposure alone (Figure S3E). IGF-1 is another myok-
ine62 whose expression was shown to be upregulated by PEMF 
exposure (Figure 1C) and is known to be highly expressed in 
oxidative muscle.44 Myokine production and release may hence 
be one limb of a greater systemic mitohormetic response that is 
capable of being evoked by PEMF treatment.
3.5 | Diversity and composition of 
gut microbiota
The cecal and fecal microbiomes from our distinct mouse co-
horts were similar in composition and did not show a large 
degree of variation at the OTU level. Therefore, rather than 
comparing gut segment-dependent changes, we pooled cecal 
and fecal microbiomes and analyzed them as a unit. The rich-
ness and diversity of the gut microbiota (fecal and cecal mi-
crobiomes) of mice subjected to the four treatment groups 
were estimated using the Chao1 and Simpson's indices, re-
spectively (Figure  5A). Based on the Simpson index, the 
microbiomes of the sedentary cohort (–E/–P) exhibited the 
greatest level of diversity. At the level of phyla their micro-
biomes were dominated by OTUs affiliated to Bacteroidetes 
(48%-57%), Firmicutes (36%-43%), Deferribacteres (3%-
5%) and Proteobacteria (1%-2%) (Figure 5B, Table S1). An 
increase in the ratio of Firmicutes/Bacteroidetes (F/B) has 
been shown to correlate with obesity in humans and mice and 
is associated with a greater capacity for energy harvest from 
the diet.81 The F/B ratio was highest in the sedentary (–E/P) 
group (1.0), followed by the PEMF-alone group (–E/+P; 
0.8), then, the exercised alone (+E/–P; 0.6) and combination 
intervention (+E/+P; 0.6) groups (Figure  5C), suggestive 
of a leaner phenotype in mice receiving PEMF treatment, 
with or without exercise. A state of leanness in exercised 
and PEMF-treated mice (+E/+P) would be metabolically 
complemented by the observed enhancements in adipose 
browning (Figure 3, Table 3), oxidative muscle development 
(Table 2 and Figures 1, S3), and PGC-1α upregulations in 
muscle and adipose tissues (Figures 1, 2, S3, and Tables 2, 3).
A PCO analysis of transformed OTU data sets from fecal 
and cecal microbiome samples showed distinct compositional 
differences in the gut microbiota between the four treatment 
groups that was statistically verified by a PERMANOVA test 
(P = .001 in 999 permutations) (Figure 5D). A PICRUSt analy-
ses was next run to determine the functional roles of the gut mi-
crobiomes of mice from the distinct treatment groups using 16S 
rRNA gene profiling. Pearson correlations (R > 0.6) were used 
to identify taxon-specific functions exhibiting linear correla-
tions to gut microbiome communities and linked to particular 
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways 
(grey circle; also see Supplemental Figure S6).
3.6 | Effect of PEMF treatment on the gut 
microbiomes of sedentary and exercised mice
LEfSe analysis was used to compare microbiome responses of 
the different treatment groups. Unexercised control mice (–E/–
P) showed greater abundances of bacterial OTUs pertaining to 
Bacteroidetes (3 OTUs), Firmicutes (10 OTUs), Tenericutes 
(4 OTUs), and Proteobacteria (2 OTUs) (Figure 6A; red). By 
contrast, unexercised, but PEMF-treated mice (–E/+P), showed 
greater abundances of OTUs belonging to the phyla Tenericutes 
(6 OTUs) and Acinetobacteria (5 OTUs) (Figure  6A; blue). 
At a deeper taxonomic level, the unexercised control mice 
(–E/–P) exhibited greater compositional diversity in OTUs 
pertaining to Rikenellaceae spp., Bacilli spp., Turicibacteriales 
spp., Clostridiaceae spp., Anaeroplasmatales spp., and 
Bilophila spp., whereas for the unexercised, but PEMF-
treated mice (–E/+P), the OTUs assigned to Tenericutes and 
Acinetobacteria showed lineages associated with Mollicutes/
RF39 and Coriobacteriales spp., Adlercreutzia spp., respec-
tively. Therefore, weekly PEMF exposure per se was capable 
of producing changes in the gut microbiota.
Exercise also elaborated unique differences in gut micro-
biomes that further individualized with supplemental PEMF 
treatment (Figure 6B). The combination of exercise and PEMF 
treatment (+E/+P; blue) elaborated greater abundances of 
OTUs assigned to Bacteroidetes (8 OTUs), Firmicutes (2 
OTUs), Proteobacteria (4 OTUs), whereas exercise alone 
(+E/–P; red) produced elevations in Bacteroidetes (3 OTUs), 
Verrucomicrobia (6 OTUs), Firmicutes (2 OTUs), and 
Acinetobacteria (2 OTUs). Specifically, the combination of 
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exercise and PEMF treatment (+E/+P) produced enrichments 
in Bacteroidales spp., Prevotella spp., Ruminococcus spp., 
Proteus spp., Betaproteobacteria spp., and Burkholderiales 
spp., whereas exercise alone (+E/–P) enriched for 
Bacteroidales spp., Verrucomicrobiales spp., Akkermansia 
muciniphila, Coprobacillus spp., and Coriobacteriaceae spp.
4 |  DISCUSSION
4.1 | PGC-1α mediates systemic effects of 
PEMF treatment
Brief PEMF exposure has been shown to stimulate 
TRPC1-NFAT-dependent transcriptional cascades, driving 
PGC-1α-dependent in vitro mitochondriogenesis and my-
ogenesis, while exhibiting a genetic propensity toward 
the oxidative phenotype.36 Here, we show that analogous 
PEMF exposure of mice (10 min/week) similarly accentu-
ated NFAT-regulated gene expression for Pgc-1α, Trpc1, 
Igf-1, and Myog (Figure 1), while enhancing oxidative mus-
cle expression (Figure 1) and improving physical capacity 
(Figure  2). Thus, the upregulation of PGC-1α-dependent 
mitochondrial and oxidative pathways was common to 
both the in vitro36 and in vivo PEMF-treated scenarios. 
PGC-1α is necessary for the establishment of systemic 
mitohormetic adaptations73 involving oxidative mus-
cle.23,71,75,82 As a result of enhanced PGC-1α deployment 
oxidative muscle exhibits a heightened propensity for fatty 
acid oxidation and insulin-sensitivity.24,51,52 Accordingly, 
F I G U R E  4  Mitohormetic genetic responses to PEMF exposure in the absence or presence of moderate exercise. A-J, Relative expression for 
the indicated mitohormetic genes. All values were normalized to control scenarios (–E/–P) shown in red far left. K-L, Absolute serum levels for 
the indicated blood markers. Mice were exposed to 1.5 mT PEMFs for 10 min/week for 8 weeks with and without moderate exercise consisting 
of twice per week running to exhaustion. All data were generated from a pool of five mice per condition. For each histogram the 1st, 2nd, 3rd, 
and 4th bars correspond to our previously delineated (–E/–P), (–E/+P), (+E/–P), and (+E/+P) cohort interventions, respectively. Red and blue 
bars correspond to 0 mT and 1.5 mT PEMF exposures in the absence (–E) or presence (+E) of twice weekly running exercise as indicated. ** and 
*P < .01 and < .05, respectively, wrt unexercised control (–E/+P).
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PGC-1α suppression characterizes diabetes-related muscle 
atrophy.56 Here, we detected PEMF-induced upregulation 
of muscular Cd36, a mitochondrial fatty acid translo-
case (Figure 1C), enhanced systemic fatty acid oxidation 
(Figure 1D) and reduced serum insulin levels (Figure 1E), 
emulating the metabolic effects more commonly associated 
with exercise.51-53 Notably, combining PEMF exposure 
with exercise accelerated the onset of Pgc-1α expression 
(Figure 2). PEMF treatment is thus capable of recapitulat-
ing recognized metabolic adaptations associated with en-
durance exercise that were dependent on PGC-1α-induced 
muscular mitochondriogenesis.44,72
Changes in the microbiome composition and function are 
also accepted exercise adaptations.2,83,84 We observed unique 
shifts in gut microbiome composition, paralleling changes 
in metabolic capacities, following PEMF treatment alone 
or in combination with exercise. Combining PEMF treat-
ment with short-term exercise enhanced Pgc-1α expression 
in skeletal muscle, WAT and BAT, whereas exercise alone 
did not (Figure  2D). On the contrary, longer-term endur-
ance exercise72 or PEMF exposure (Figure  1C) are either 
capable of upregulating Pgc-1α expression and downstream 
mitochondriogenesis. The fact that the PPAR/PGC-1α mito-
chondrial pathways and the microbiome interact for mutual 
F I G U R E  5  Diversity and characteristics of gut microbial community in female mice of different intervention groups. A, Alpha diversities 
(Chao1 and Simpson indices) of microbial communities in fecal and cecal contents of mice. B, Relative abundance of OTUs (assigned to the 
Phyla level) in the gut microbiomes of mice. C, Relative abundance and ratios of OTUs assigned to Firmicutes (hatched) and Bacteroidetes 
(solid). D, A Principal Coordinate Analysis (PCO) of microbial communities in fecal and cecal contents of mice from the four treatment groups. 
The microbiomes of different treatment groups are indicated by color and a PERMANOVA (Permutational multivariate analysis of variance) test 
indicate significant differences (P = .001) in OTU composition between treatments. Pairwise PERMANOVA tests between each treatment showed 
significant differences (P < .05).
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reinforcement in effect closes the loop between muscle (large 
activatable pool of mitochondria) and microbiome func-
tion.85 Indeed, bidirectional communication between the gut 
microbiome and muscle mitochondria is now supported by 
numerous studies demonstrating that muscle mitochondria 
and the commensal gut microbiota cross talk (via the SCFAs 
that potentiate PGC-1α function) to modulate redox balance 
and systemic inflammation.17,86,87
Adipose beiging is another accepted exercise adaptation 
that is likewise dependent on PGC-1α expression and asso-
ciated changes in mitochondrial function and biogenesis.88,89 
In the short-term, the combination of PEMF treatment plus 
exercise (+E/+P) upregulated Pgc-1α and Ucp1 expression 
in WAT and BAT (Table 3) as well as produced alterations 
in gut microbiome composition indicative of reduced adipos-
ity (Figure 5). Obesity is associated with a high F/B ratio in 
mice90 and humans.91 Our unexercised control group of mice 
(–E/–P) exhibited the highest F/B ratio (1.0) with PEMF 
treatment alone (–E/+P) contributing a reduction in the ratio 
to 0.8; exercise alone (+E/–P) or the combination of PEMF 
treatment and exercise (+E/+P) lowered the F/B ratio further 
to a common level of 0.6 (Figure 5). PEMF treatment hence 
induced similar, albeit more modest, shifts in the gut microbi-
ome F/B ratio as exhaustive exercise after 6 weeks.
4.2 | Microbiome adaptations to PEMF and 
exercise interventions
A majority of the OTUs in the strenuously exercised cohort of 
mice, independent of PEMF treatment, pertained to the order 
Bacteroidales, dominated by the S24-7 family. This form of 
exercise by itself selected for gut bacteria involved in energy 
metabolism including S24-7, Coriobacteriaceae spp. and 
members of Verrucomicrobia and Akkermansia spp., previ-
ously shown to be inversely correlated with obesity, metabolic 
disorders, and inflammation.92 Akkermansia muciniphila is 
a known butyrate (SCFA) producer that is associated with 
a lean body mass and improved metabolic health.93,94 The 
gut microbiomes of PEMF-treated unexercised mice (–E/+P) 
were enriched in Coriobacteriaceae spp. and Adlercreutzia 
linked to lipid metabolism95 and interscapular BAT thermo-
genesis and leanness in mice,96 respectively. Thus, although 
6 weeks of PEMF treatment alone was insufficient to achieve 
F I G U R E  6  Taxonomic differences between the gut microbiomes of (A) unexercised, PEMF-treated (–E/+P; blue) and non-PEMF-treated 
(–E/−P; red) and (B) exercised, PEMF-treated (+E/+P; blue) and non-PEMF-treated (+E/−P; red) cohorts of female mice by linear discriminant 
analysis effect size (LEfSe) analysis. Cladograms represented by the LDA model show differentially abundant OTUs for paired treatment groups 
being tested.
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beiging in WAT per se, the observed microbiome shifts were 
predictive of a leaner phenotype (lower F/B ratio) and exhib-
ited correlations with greater thermogenic capacity.
By far, the most pronounced changes in muscle develop-
ment and adipose thermogenesis were observed in the com-
bined PEMF treatment and strenuously exercised (+E/+P) 
group. These mice showed enrichments of gut commen-
sals including Bacteroidales spp., Prevotella spp., and 
Ruminococcus spp., which have been linked to improved en-
ergy metabolism in mice97 and reduced incidence of weight 
gain in humans.3 Burkholderiales was also enriched in this 
cohort and has been correlated with exercise adaptations 
in mice.98 Here, we show that the microbial makeup of the 
strenuously exercised and PEMF-treated group (+E/+P) 
correlated with transcriptional upregulations indicative of 
adipose browning and thermogenesis (Ucp1), improved in-
sulin-sensitivity (Glut4, Irs1, Lep) and mitochondriogenesis 
(Cox7a1, Pgc-1α) (Figure 3 and Table 3).
Exercise is an inflammatory stimulus that paves the 
way for physical and metabolic adaptations to oxidative 
stress,99,100 a mitohormetic process73,82,101 instigated by 
Pgc-1α.102 Although the PEMF exposure paradigm used 
in the present report was relatively innocuous (60  minutes 
of total exposure distributed over 6  weeks at 1.5 mT) and 
previously provided no indications of cellular stress,36 here, 
we combined it with an exercise regimen that was exhaus-
tive by design, which in combination with PEMF treatment 
may have achieved a threshold level of inflammatory stress. 
The detection of Proteus spp., a pathobiont implicated in 
Inflammatory Bowel Disease103 and Coprobacillus spp., im-
plicated in gastrointestinal disease,104 suggest that the com-
bination of exhaustive exercise and weekly PEMF exposure 
(+E/+P) produced a level of oxidative stress not achieved in 
the exclusive exercised (+E/–P) or PEMF-treated (–E/+P) 
cohorts (Figure 2). For the dual intervention (+E/+P) cohort, 
an elevated level of inflammation may have produced a state 
of dysbiosis105 manifested as a reduction in taxonomic di-
versity that may have enabled pathobionts to outcompete gut 
commensals, a process known as the competitive exclusion 
effect.106 Conversely, the reduced diversity observed in the 
exclusive exercise (+E/–P) or PEMF-treated (–E/+P) cohorts 
may indicate microbiomal adaptations to enhance fidelity at 
the expense of diversity.107 Further studies are required to re-
solve between these possibilities.
4.3 | Magnetic mitohormesis
We previously showed that PEMF exposure acts to instill 
mitochondrial survival adaptations associated with PGC-1α 
expression, a process of magnetically induced mitohorme-
sis.36 The data reported here would indicate that PEMF ex-
posure is analogously inducing systemic mitohormesis in 
vivo. Muscular mitochondrial activation82,101 and PGC-1α 
expression are recognized systemic mitohormesis inducers, 
mediated by PGC-1α/NRF/PPAR transcriptional coactiva-
tion of adaptive mitochondrial function.57,71,73,82 These are 
genetic features shared by both exercise and the presented 
magnetic field intervention (Figures 1, 2, 4 and Tables 2, 3). 
The possibilities thus exist that magnetic field treatment may 
combine with concurrent exercise to either: (a) produce ben-
eficial outcomes at low levels of cumulative mitochondrial 
activation or; (b) produce a restrictive inflammatory response 
resulting from excessively combined oxidative stresses; both 
these scenarios are in line with a mitohormetic mechanism 
and moreover, may represent different temporal stages of 
an ultimate unified adaptive response. In our 6-week ex-
haustive exercise study mice were exposed once per week 
(Sunday) and run to exhaustion thrice weekly on Mondays, 
Wednesdays, and Fridays. Running performance was gen-
erally slowest on Monday (greatest cumulative oxidative 
stress) and fastest on Friday (least cumulative oxidative 
stress), providing evidence of metabolically overwhelming 
interactions with greater temporal coincidence of the two 
interventions (Supplemental Figure S5); nonetheless, in the 
end the combination of PEMF exposure and exercise pro-
duced a greater level of physical adaptation. Microbiome and 
adipose measurements also produced signs of stressful sys-
temic inflammation in mice undergoing both strenuous exer-
cise and PEMF treatments (Figure 2B). Indeed, low levels of 
chronic stress have been shown to induce adipose browning 
in mice,108 which aligns with the results reported for adipose 
tissues reported in this study. It is thus imperative that the 
timing of PEMF exposure as well as the level of exertion 
within the exercise regimen be adjusted to provide an optimal 
mitohormetic stimulus for positive adaptation, and moreover, 
may need to be intermittently gauged to match the basal level 
of inflammation of recipients as it changes during the course 
of the trial. Therefore, although the results represented in 
this report are consistent with the interpretation that PEMF 
exposure is inducing systemic mitohormetic adaptations, an 
analysis of the deeper systemic implications of our magnetic 
field exposure paradigm in animals and humans is warranted.
4.4 | Myokine response
CR (caloric restriction) browns and reduces adiposity, meta-
bolic changes that are also correlated with alterations in the 
composition of the gut microbiota.35 CR also stimulates mus-
cular mitochondriogenesis and improves systemic insulin-
sensitivity via the actions of SIRT1 and PGC-1α.11,78,109 It 
is thus feasible that CR mediates its systemic effects largely 
by acting on the extensive muscular mitochondria pool. One 
manner in which the muscular mitochondrial pool would 
be capable of transmitting their response to the “system” is 
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via the release of myokines upon the activation of muscu-
lar mitochondrial respiration,31-33,62,63 as PEMFs have been 
previously shown capable of doing.36 Given that PEMF ex-
posure36 (Figures 1, 4), exercise,23,51 and CR11,78,109 all have 
in common that they activate SIRT1 and PGC-1α, similar 
myokine responses are likely to be elicited by any of the 
aforementioned interventions. Provocatively, myokines have 
been shown to induce the beiging of white adipose, ulti-
mately stimulating its production and release of batokines, 
some of which are common to both cytokine pools and 
known as adipo-myokines34,110 such as IGF-1 (Figure 1C), 
VEGFA (Figure  S3E), adiponectin (Figure  4L), and IL-6 
(Figure 4M), reinforcing the overall systemic response. The 
PEMF-induced mobilization of myokines and adipokines re-
ported here hence supports such a physiological scheme. In 
further support of such a mechanism, it was recently shown 
that PEMF exposure augments the secretome response of 
MSCs to possess heightened anti-inflammatory and pro-
chondrogenic properties.111 Our future studies will focus on 
the PEMF-induced muscle and adipose secretome responses 
in animals and humans and their contributions to a greater 
systemic mitohormetic response.
4.5 | Functional profiles of PEMF- and 
exercise-conditioned gut microbiota
The microbiomes of the unexercised control cohort (–E/–P) 
did not show any significant associations to specific KEGG 
functions. By contrast, the microbiota of the unexercised, but 
PEMF-treated cohort (–E/+P) were better adapted for car-
bohydrate (mannose and fructose) and nucleotide (purine) 
metabolism as well as amino acid transport. Notably, this 
cohort also exhibited a microbiota that was particularly well 
suited for ketone body synthesis and metabolism (Figure S6), 
likely resulting from elevated mitochondrial fatty acid oxida-
tion (Figure 1C,D), indicating that PEMF treatment per se is 
capable of altering gut microbiomes to better support meta-
bolic flexibility (Figures  4I, S6). Moreover, ketone bodies 
have been proposed to act as signaling molecules to induce 
states of systemic mitohormesis15,112 in association with the 
PGC-1α-NRF1/2-TFAM mitochondrial cascade (Figure  4). 
The exercised alone cohort  (+E/–P), on the contrary, had 
greater representations from KEGG genes concerned with 
energy metabolism (oxidative phosphorylation) and metabo-
lism of cofactors and vitamins (ubiquinone and terpenoid, 
biotin). Finally, the combined exercise and PEMF cohort 
(+E/+P) exhibited gut microbiomes that were functionally 
geared for the transport and exchange of glutamate and as-
partate with the host. These amino acids are precursors in 
the synthesis of the SCFAs, known to modulate obesity113 
and recognized PPAR agonists targeted to muscle.85 Notably, 
butyrate is known to induce PGC-1α gene expression in 
skeletal muscleand adipose tissue as well as stimulates free 
fatty acid oxidation,17 aligning with the results presented in 
this study. Enterocytes also use glutamate and aspartate as 
an energy source during epithelial layer renewal and nutrient 
absorption.114,115 Finally, glutamate is also thought to play a 
central role in the bidirectional communication system be-
tween the “microbiota-gut-brain axis” through modulation of 
glutamatergic receptor activity.116
4.6 | Extraneous contributing factors
The possibility that extraneous factors may have contributed 
to the results reported here cannot be discounted. To con-
trol for collateral effects attributed to mouse handling, both 
control and experimental mice were placed into the PEMF 
device for the same period of time (10  minutes), with the 
exception that control mice did not receive active fields. 
Notably, weight gain was sometimes seen in mice under-
going PEMF treatment, but was not consistently observed. 
One possibility is that the handling of mice may have been 
perceived as a form of stress. Stress is known to cause sig-
nificant weight loss in several strains of mice.117 Therefore, 
stress, in one form or another, may have contributed to the 
variability in weight gain we observed, particularly in studies 
where mice received multiple weekly exposures to PEMFs. 
Supplemental Figure S7 shows the observed weight changes 
for the longest and shortest duration studies included in this 
report, 6 months, single (Figure S7A) and thrice (Figure S7B) 
weekly exposure in the absence of exercise, and 6  weeks, 
single weekly PEMF exposure in combination with exercise 
(Figure S7C). Interestingly, weight gain in the once weekly 
exposed long-term cohort was not correlated with significant 
changes in food (Figure S7D) or water (Figure S7G) intake, 
whereas the thrice weekly exposed cohorts, not experiencing 
PEMF-induced changes in weight gain, did reveal a trend to 
increase food (Figure S7E) and water (Figure S7H) intake. 
On the other hand, increases and decreases in serum free fatty 
acids (FFA) (Figure S7J) and triglyceride (TG) (Figure S7M) 
levels, respectively, were observed in the long-term singly 
exposed mouse cohort, but not the thrice weekly exposed co-
hort (Figure S7K,N). In agreement, it has been reported that 
exercise training stimulates adipose TG hydrolysis to pro-
duce FFAs for release into the general circulation for use by 
muscle as an energy substrate,118 reflecting our reported en-
hancement in fatty acid oxidation (Figure 1D). Accordingly, 
the Respiratory Exchange Ratio (RER) consistently showed 
a tendency to decrease with PEMF exposure in all mouse 
cohorts (Figure  S7S-U; also cf Figure  1D). No correlation 
was observed between magnitude of weight gain and any of 
the measured parameters achieving statistical significance in 
the long-term study. Succinctly, weight gain was variable, 
likely subject to collateral as well as experimental variables 
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yet, not clearly correlated to any of the measured metabolic 
changes. The interactions between the duration and fre-
quency of PEMF therapy with environmental stressors and 
consequently, with inherent stress responses, hence, require 
further studying. Handling-induced stress, however, would 
likely prove more consequential in small animal studies than 
in eventual human trials. Therefore, however provocative, 
these responses need to be confirmed with studies on larger 
cohorts of animals with greater number of independent vari-
ables with implemented controls for environmental stressors.
The results reported here indicate that PGC-1α is a com-
mon mediator of the metabolic effects of both exercise and 
PEMF treatment. In the short-term (≤6  weeks) a stronger 
statistical interaction was observed between Pgc-1α and re-
lated mitochondrial gene expressions with PEMF treatment, 
whereas adipose markers associated with insulin-sensitiv-
ity exhibited a stronger statistical interaction with exercise. 
Equally short-term PEMF treatment and exercise also pro-
duced unique shifts in microbiome communities and func-
tional signatures with known associations to energy balance, 
while exhibiting low intragroup variability. Nonetheless, 
many key features previously associated with exercise-in-
duced activation of PGC-1α were similarly evoked by PEMF 
treatment per se when administered for a few months includ-
ing mitohormetic gene expression, oxidative muscle expres-
sion, enhanced mitochondrial fatty acid oxidation, systemic 
fatty acid oxidation, and insulin-sensitivity. We also revealed 
a novel association between magnetic field exposure and gut 
microbiome functional shifts toward metabolic improve-
ment, implying a mutual link to PGC-1α. These metabolic 
responses, associated with PEMF exposure and/or exercise, 
despite being correlative, were internally consistent at sev-
eral levels of physiological interaction and in agreement with 
published literature relating to the effects of muscle mito-
chondrial activation by exercise, as well as are in line with the 
predictions of our prior in vitro mechanistic studies showing 
PGC-1α upregulation in response to magnetic stimulation.36 
PEMF-based technologies hence may be ultimately exploited 
to complement, or accentuate, certain metabolic and physical 
attributes of exercise in humans unable to exercise because of 
illness, injury, or advanced age.
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